Cargando…

Suppression of YAP by DDP disrupts colon tumor progression

Mostrar otras versiones (1)

Colon cancer is a commonly diagnosed cancer that often has a poor prognosis. Combined with the development of drug resistance to cancer treatment agents the treatment efficacy of colon cancer can be limited. Activation of the oncogene YAP has been shown to be related to colon cancer progression and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kun, Guo, Jiwei, Wu, Yan, Jin, Dan, Jiang, Hong, Liu, Chengxia, Qin, Chengyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928767/ https://www.ncbi.nlm.nih.gov/pubmed/29512779 http://dx.doi.org/10.3892/or.2018.6297

Ejemplares similares

Suppression of YAP by DDP disrupts colon tumor progression
por: Li, Kun, et al.
Publicado: (2021)

Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment
por: Du, Jing, et al.
Publicado: (2017)

Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment
por: Du, Jing, et al.
Publicado: (2020)

Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016)

Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma
por: Cheng, Jiwei, et al.
Publicado: (2022)

Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions
por: Jiang, Zhengdong, et al.
Publicado: (2018)

Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2020)

Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis in Human Gastric Cancer SGC-7901/DDP Cells
por: Tang, Qing-Feng, et al.
Publicado: (2014)

Correction: Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2022)

The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC
por: Jin, Dan, et al.
Publicado: (2018)

Neogenin suppresses tumor progression and metastasis via inhibiting Merlin/YAP signaling
por: Hu, Xiaohan, et al.
Publicado: (2023)

ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
por: Gu, Yan, et al.
Publicado: (2021)

Targeting YAP-dependent MDSC infiltration impairs tumor progression
por: Wang, Guocan, et al.
Publicado: (2015)

Retraction notice to ‘The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC’ [EBioMedicine 37 (2018) 188–204]
por: Jin, Dan, et al.
Publicado: (2021)

YAP at the progression of inflammation
por: Chen, Libin, et al.
Publicado: (2023)

Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
por: Huang, Yan-Jiun, et al.
Publicado: (2017)

m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
por: Jin, Dan, et al.
Publicado: (2020)

Yap suppresses T-cell function and infiltration in the tumor microenvironment
por: Stampouloglou, Eleni, et al.
Publicado: (2020)

Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
por: Jin, Dan, et al.
Publicado: (2022)

DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP
por: Liu, Ronghua, et al.
Publicado: (2020)

Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
por: Gu, Yan, et al.
Publicado: (2023)

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
por: Xu, Jiayun, et al.
Publicado: (2022)

m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2019)

m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2021)

Retraction: DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP
por: Liu, Ronghua, et al.
Publicado: (2021)

Correction to: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2020)

microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells
por: Wang, Zhigang, et al.
Publicado: (2019)

Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2023)

Expression of concern: DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP
por: Liu, Ronghua, et al.
Publicado: (2021)

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway
por: Jin, Dan, et al.
Publicado: (2018)

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway
por: Jin, Dan, et al.
Publicado: (2021)

Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors
por: Liu, Chao, et al.
Publicado: (2018)

The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
por: Guo, Ting, et al.
Publicado: (2022)

Suppression of YAP safeguards human naïve pluripotency
por: Dattani, Anish, et al.
Publicado: (2022)

PP-DDP: a privacy-preserving outsourcing framework for solving the double digest problem
por: Suo, Jingwen, et al.
Publicado: (2023)

CircASXL1 Knockdown Restrains Hypoxia-Induced DDP Resistance and NSCLC Progression by Sponging miR-206
por: Yu, Liuyang, et al.
Publicado: (2021)

MicroRNA-708 Suppresses Cell Proliferation and Enhances Chemosensitivity of Cervical Cancer Cells to cDDP by Negatively Targeting Timeless
por: Zou, Xinwei, et al.
Publicado: (2020)

miR-590-5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression
por: Mou, Kuanhou, et al.
Publicado: (2018)

The reversal effect of magnetic Fe(3)O(4) nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells
por: Jiang, Zhi, et al.
Publicado: (2009)

Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway
por: Guo, Ruowen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d63mflok6k8s19eeadres7sn47